Science Explorer Back to mapMap
Discussion
Researcher · Medscape · United States

Nimish Mehta

Nimish Mehta publishes mostly in Pulmonary and Respiratory Medicine, Organic Chemistry and Epidemiology, on topics such as Pulmonary Hypertension Research and Treatments, Adenosine and Purinergic Signaling and Mycobacterium research and diagnosis.

OpenAlex
World rank
#7,173,011
of 7,710,434 ranked researchers
Rank in United States
#1,589,252
of 1,627,098
Works
26
Citations
72
Citations per work
2.8
h-index
5
i10-index 2Top 85% in Pulmonary and Respiratory Medicine
Nimish Mehta

What does Nimish Mehta research?

Nimish Mehta's work is mostly in Medicine (29%), Chemistry (7%), Health Professions (5%).

Everything else: 15 works · 59.2% of their workHealth Sciences: 9 works · 34.0% of their workMedicine: 8 works · 28.9% of their workPulmonary and Respiratory Medicine: 4 works · 13.6% of their workEpidemiology: 2 works · 6.8% of their workGenetics: 1 works · 5.1% of their workOphthalmology: 1 works · 3.4% of their workHealth Professions: 1 works · 5.1% of their workGeneral Health Professions: 1 works · 5.1% of their workPhysical Sciences: 2 works · 6.8% of their workChemistry: 2 works · 6.8% of their workOrganic Chemistry: 2 works · 6.8% of their workTHEIR WORKNimish Mehta26works
Physical Sciences7%Health Sciences34%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1559.2%
    1. Medicine828.9%
    2. Health Professions15.1%
    1. Chemistry26.8%
  1. 1Pulmonary and Respiratory Medicine14% of their works
  2. 2Organic Chemistry7% of their works
  3. 3Epidemiology7% of their works
  4. 4Genetics5% of their works
  5. 5General Health Professions5% of their works
  6. 6Ophthalmology3% of their works

Research topics

Which keywords describe Nimish Mehta's research?

The keywords of their largest research topics: Endothelial Dysfunction, Inflammation, Pulmonary Hypertension, Right Heart Assessment, Diagnosis, Drug Resistance, Epidemiology and Adenosine Receptors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Endothelial Dysfunction72 topics
  2. Inflammation63 topics
  3. Pulmonary Hypertension51 topic
  4. Right Heart Assessment51 topic
  5. Diagnosis42 topics
  6. Drug Resistance42 topics
  7. Epidemiology42 topics
  8. Adenosine Receptors21 topic
  9. Epilepsy21 topic
  10. Hyperuricemia21 topic
  11. Inhaler Devices21 topic
  12. Mycobacterium avium21 topic
  13. Mycobacterium tuberculosis21 topic
  14. Nontuberculous Mycobacteria21 topic
  15. Pulmonary Drug Delivery21 topic
  16. Purinergic Signalling21 topic
  17. Seizures21 topic
  18. Tuberculosis21 topic
  19. Uric Acid21 topic
  20. Biochemical Genetics11 topic
  21. Metabolic Disorders11 topic

Where does Nimish Mehta work?

Nimish Mehta's main affiliation in the publication record is Medscape, United States.

How many publications and citations does Nimish Mehta have?

OpenAlex counts 26 works and 72 citations for Nimish Mehta, an h-index of 5, ranking #7,173,011 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nimish Mehta. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.